We found that midnolin expression correlates with poor prognosis in HCC patients, and suppression of midnolin severely inhibits growth of HCC cells in vitro and in mice and disrupts retinoic acid/lipid metabolism in these cells. Here, MIDN is linked to hepatocellular carcinoma.